Last week, between 24 and 26 November, the 5th International Health Regulation Meeting was held. This is a global congress where regulatory experts and state health agencies from all over the world discuss current issues in the sector. Mercè Camps participated in a panel discussion on the regulation of medical devices in the EU.
The 5th International Meeting on Health Regulation has been organised by AMEPRESThe Mexican Association of Professionals in Health Regulation of the Health Inputs Industry (Asociación Mexicana de Profesionales en Regulación Sanitaria de la Industria de Insumos para la Salud).
Because of its international vocation, the following were invited to participate national health agencies -including the AEMPS - and a large number of health regulation experts from the following countries: Argentina, Brazil, Canada, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Peru, Spain, Switzerland, United Kingdom, United States and Dominican Republic.
The meeting was informed about the main changes in the regulatory framework for medicines and medical devices -health products - in Latin America. In addition, it was announced that the actions of participating health authorities in combating the COVID-19 pandemic. It also discussed the importance of - "counting onn regulatory policies and smart regulatory systems"The participants also discussed how to make the regulatory processes more efficient. And finally, there was a discussion on the harmonisation, convergence and relianceand on the importance of these three concepts in order to make it possible to implement the smart regulatory systems.
International guest speakers included Mercè Campsdirector of Technical Pharmaceutical Officewho participated in a panel discussion on the regulation of medical devices in the EU.
Spanish representation at the international meeting
The 5th International Meeting on Health Regulation The meeting was attended by two participants who are experts in health regulation in Spain: a technician responsible for AEMPSand the director of our office Mercè Campswho participated in two of the scheduled events:
- Directed a round table on the new European Regulation on Medical Devices.
- Participating in another round table discussion on the policies being taken in relation to COVID-19.
From GTF, we value very positively the two interventions of our director, Mercè Camps, which allowed to solve before a huge audience -mainly composed of regulatory technicians from Central and Latin America- some doubts about the regulation of medical devices in the Eurozone.
A lecture on the regulation of medical devices by Mercè Camps
These were the topics discussed during the round table led by Mercè Camps at the meeting:
Part 1: New Regulation 745/2017 on Medical Devices:
- What we mean
- Definition
- Objectives of the Regulation
- Legislative Framework for Medical Devices
- Classification of Medical Devices
- What's new in the Regulation?
- Economic Actors
Part 2: CE marking
- Medical devices and CE marking
- Affixing the CE marking
- Implications of CE marking
- CE marked products
- Harmonised standards in the European Union
- Notified Body
- Accreditation Documents
Latest articles in our blog
Rapex Report 2016: all the data in an infographic
As we start a new year, it is time to present the Rapex Report 2016, a report on our weekly monitoring of the European Commission's Rapid Alert System alerts. Later on, we hope to present a more detailed article, with many more...
Course on cosmetics and medical devices regulation
On Tuesday 20 and Wednesday 21 December, Mercè Camps, director of the Technical Pharmaceutical Cabinet M. Camps, travelled to Salamanca to give a course on Cosmetics and Medical Devices Regulations at the headquarters of Aquimisa Pharma. This proposal...
Take your pulse: prevention campaign in pharmacies
The first phase of Tómate el pulso -Pren-te el pols, in Catalan- began on 7 November. This is a health promotion campaign, which aims to detect arrhythmias among people over 60 years of age, and thus prevent heart attacks and stroke.